Insider Transactions in Q4 2023 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2023
|
Christopher S. Boerner Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+2.36%
|
$98,000
$49.78 P/Share
|
|
Dec 02
2023
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,350
-1.65%
|
$67,500
$50.1 P/Share
|
|
Dec 02
2023
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,638
+3.12%
|
-
|
|
Dec 02
2023
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,730
-2.16%
|
$186,500
$50.1 P/Share
|
|
Dec 02
2023
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,792
+4.85%
|
-
|
|
Dec 02
2023
|
Robert M Plenge EVP, Chief Research Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-3.81%
|
$13,700
$50.1 P/Share
|
|
Dec 02
2023
|
Robert M Plenge EVP, Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+7.88%
|
-
|
|
Nov 28
2023
|
Christopher S. Boerner Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,071
+3.72%
|
$147,408
$48.86 P/Share
|
|
Nov 21
2023
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Indirect |
9,830
+9.52%
|
$471,840
$48.74 P/Share
|
|
Nov 21
2023
|
Sandra Leung EVP, General Counsel |
SELL
Other acquisition or disposition
|
Direct |
9,830
-2.88%
|
$471,840
$48.74 P/Share
|
|
Nov 20
2023
|
Theodore R. Samuels Ii Director |
BUY
Open market or private purchase
|
Direct |
8,500
+19.32%
|
$416,500
$49.81 P/Share
|
|
Oct 10
2023
|
Giovanni Caforio Executive Chair of the Board |
SELL
Bona fide gift
|
Direct |
440
-0.12%
|
-
|